0001493152-25-003393.txt : 20250123 0001493152-25-003393.hdr.sgml : 20250123 20250123161546 ACCESSION NUMBER: 0001493152-25-003393 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250123 DATE AS OF CHANGE: 20250123 EFFECTIVENESS DATE: 20250123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genesis BioCapital Fund I, LP CENTRAL INDEX KEY: 0002053141 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-536080 FILM NUMBER: 25550326 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8400 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0002053141 Genesis BioCapital Fund I, LP 245 FIRST STREET 18TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 617-444-8400 DELAWARE None None Limited Partnership true 2024 - Genesis BioCapital Fund I GP, LP 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer General Partner - Genesis BioCapital Management, LLC 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Investment Manager Ray Tabibiazar 245 First Street 18th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 Indefinite 0 Indefinite false 0 0 0 0 true The Investment Manager will receive a fee based on each limited partner's capital commitments and the General Partner may receive incentive distributions as more fully set forth in the offering materials. false Genesis BioCapital Fund I, LP /s/ Ray Tabibiazar Ray Tabibiazar Authorized Signatory 2025-01-23